Gilles Martin (#1338)
- $ 3 B
- Laboratory services
- France
- M
- 62 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Gilles Martin is the executive chairman of Eurofins Scientific, a Luxembourg-based laboratory services company listed on the French stock exchange. Martin, who founded the original lab in 1987, owns an estimated 22% of the company through the family's holding company Analytical Bioventures. His brother Yves-Loic owns an estimated 10% stake. He served as CTO from 1998 until 2015 and now is a board member. Eurofins has 900 labs in 61 countries and is prominent in food and pharmaceutical products testing.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Gilles Martin’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Gilles Martin’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $3.2B
(May 4, 2026)
© Iconic Billionaires